Alnylam Pharmaceuticals (ALNY) Q2 2015 Earnings

7MayConfirmed
Q3 2014
Q4 2014
Q1 2015
Q2 2015
-0.65
-0.53
-0.4
-0.28

Details

Expected EPS
-0.65
Actual EPS
-0.62
Surprise EPS
0.03
Surprise Percent
+4.62%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.62 per share for Q2 2015.

0 Comments

Share your thoughts